Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Atosiban [1] Atosiban[1] D03008 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 118
2 Methamidophos [1] MONITOR---[20] 2, 11, 13, 19, 28, 46, 49, 58, 65, 70, 81, 85, 86, 98, 113, 118, 129, 298, 299, 300
3 Methylergometrine [0] [2] D00680 ,
D08207 		[6] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C 💬		[7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[3] 118, 280, 288
4 Mitomycin [2] Mitomycin; Mitomycin C[1] D00208 --[3] 94, 118, 329
5 Placental Mesenchymal Stem Cells [2] Placental Mesenchymal Stem Cells; PLX-PAD---[2] 86, 118
6 Sulfanilamide [0] [1] D08543 --[5] 6, 30, 60, 118, 298
7 Terbutaline [1] Terbutaline[2] D00688 ,
D08570 		[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 118